FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...

Dexcom, Inc. (NASDAQ: DXCM) issues this press release to supplement its previous customer notification and remind its patients to periodically test the audible alarms and alerts on certain receivers ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version. In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some ...

Dexcom has announced it has received FDA approval of a new continuous glucose monitoring system, according to a news release. The Dexcom G4 PLATINUM system consists of three parts: a sensor, ...

The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...

Jonas, Who Has Type 1 Diabetes, Sings Praises for the Life-Changing Impact of Continuous Glucose Monitoring San Diego, CA, June 11, 2015 – Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose ...

DexCom, Inc.DXCM recently announced the signing of a development agreement with Eli Lilly and Company LLY. Per the agreement, DexCom's flagship continuous glucose monitoring system (CGM) will be added ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had improvements in glycemic control after switching from an intermittently scanned ...